{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:47:30Z","timestamp":1793533650747,"version":"4.5.0"},"reference-count":79,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamaneurol.2022.0067","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T16:04:22Z","timestamp":1646669062000},"page":"405","source":"Crossref","is-referenced-by-count":44,"title":["Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A Review"],"prefix":"10.1001","volume":"79","author":[{"given":"Sarah U.","family":"Morton","sequence":"first","affiliation":[{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Department of Paediatrics, University of Melbourne, Melbourne, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Costain","sequence":"additional","affiliation":[{"name":"Division of Clinical & Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Program for Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom"},{"name":"North East Thames Regional Genetic Service, Great Ormond Street Hospital Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wakeling","sequence":"additional","affiliation":[{"name":"North East Thames Regional Genetic Service, Great Ormond Street Hospital Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica H.","family":"Wojcik","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"The Manton Center for Orphan Disease Research, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Genetics and Genomics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney E.","family":"French","sequence":"additional","affiliation":[{"name":"Division of Genetics and Genomics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szuto","sequence":"additional","affiliation":[{"name":"Department of Genetic Counselling, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dowling","sequence":"additional","affiliation":[{"name":"Program for Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Cohn","sequence":"additional","affiliation":[{"name":"Division of Clinical & Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Program for Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Lucy","family":"Raymond","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil T.","family":"Darras","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Hematology\/Oncology, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lunke","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Department of Paediatrics, University of Melbourne, Melbourne, Australia"},{"name":"Department of Pathology, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zornitza","family":"Stark","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Department of Paediatrics, University of Melbourne, Melbourne, Australia"},{"name":"Australian Genomics Health Alliance, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Rowitch","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom"},{"name":"Division of Neonatology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj B.","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"The Manton Center for Orphan Disease Research, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Genetics and Genomics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"nrv220001r1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.clp.2015.02.008","article-title":"Neonatal hypotonia.","volume":"42","author":"Sparks","year":"2015","journal-title":"Clin Perinatol"},{"issue":"7","key":"nrv220001r2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1469-8749.2011.03918.x","article-title":"Genetic evaluation of the pediatric patient with hypotonia: perspective from a hypotonia specialty clinic and review of the literature.","volume":"53","author":"Lisi","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"nrv220001r3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.spen.2008.01.003","article-title":"The evaluation of the hypotonic infant.","volume":"15","author":"Bodensteiner","year":"2008","journal-title":"Semin Pediatr Neurol"},{"key":"nrv220001r4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/B978-0-444-59565-2.00001-0","article-title":"Diagnostic workup for neuromuscular diseases.","volume":"113","author":"Fardeau","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"nrv220001r5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.siny.2010.11.002","article-title":"Genetic evaluation of the floppy infant.","volume":"16","author":"Prasad","year":"2011","journal-title":"Semin Fetal Neonatal Med"},{"issue":"18","key":"nrv220001r6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy.","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"nrv220001r7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy.","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"nrv220001r8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study.","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"nrv220001r9","first-page":"45","article-title":"Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants.","volume":"69","author":"Bacher\u00e9","year":"2008","journal-title":"Horm Res"},{"issue":"3","key":"nrv220001r10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0729","article-title":"Gene therapy for spinal muscular atrophy: safety and early outcomes.","volume":"146","author":"Waldrop","year":"2020","journal-title":"Pediatrics"},{"issue":"6148","key":"nrv220001r11","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"nrv220001r12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.spen.2019.01.004","article-title":"Therapeutic aspects in congenital myopathies.","volume":"29","author":"Jungbluth","year":"2019","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"nrv220001r13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00431-007-0539-3","article-title":"Diagnostic approach to neonatal hypotonia: retrospective study on 144 neonates.","volume":"167","author":"Laugel","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"4","key":"nrv220001r14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome\u2014clinical genetics, diagnosis and treatment approaches: an update.","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"nrv220001r15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jpeds.2014.01.039","article-title":"Prevalence of Prader-Willi syndrome among infants with hypotonia.","volume":"164","author":"Tuysuz","year":"2014","journal-title":"J Pediatr"},{"key":"nrv220001r16","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2019.08.007","article-title":"Neuromuscular diseases of the newborn.","volume":"32","author":"Fay","year":"2019","journal-title":"Semin Pediatr Neurol"},{"issue":"9","key":"nrv220001r17","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1542\/pir.30.9.e66","article-title":"The floppy infant: evaluation of hypotonia.","volume":"30","author":"Peredo","year":"2009","journal-title":"Pediatr Rev"},{"issue":"2","key":"nrv220001r18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies.","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"nrv220001r19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104533","article-title":"Molecular genetics of congenital myotonic dystrophy.","volume":"132","author":"Lanni","year":"2019","journal-title":"Neurobiol Dis"},{"key":"nrv220001r20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/B978-0-444-64029-1.00021-7","article-title":"Neonatal hypotonia and neuromuscular conditions.","volume":"162","author":"Mercuri","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"nrv220001r21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"nrv220001r22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nmd.2004.12.005","article-title":"Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism.","volume":"15","author":"Tsai","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"nrv220001r23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.pediatrneurol.2014.07.032","article-title":"Use of next-generation sequencing as a diagnostic tool for congenital myasthenic syndrome.","volume":"51","author":"Das","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"5","key":"nrv220001r24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10545-015-9836-6","article-title":"Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations.","volume":"38","author":"Huemer","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"nrv220001r25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s13311-013-0177-6","article-title":"Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.","volume":"10","author":"El-Hattab","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"7","key":"nrv220001r26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41372-020-0697-y","article-title":"Genetic testing strategies in the newborn.","volume":"40","author":"Carroll","year":"2020","journal-title":"J Perinatol"},{"issue":"4","key":"nrv220001r27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","article-title":"Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.","volume":"20","author":"Lionel","year":"2018","journal-title":"Genet Med"},{"issue":"9","key":"nrv220001r28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.18109","article-title":"Genome sequencing as a diagnostic test in children with unexplained medical complexity.","volume":"3","author":"Costain","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"nrv220001r29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.","volume":"3","author":"Clark","year":"2018","journal-title":"NPJ Genom Med"},{"key":"nrv220001r30","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/npjgenmed.2015.12","article-title":"Whole genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine.","volume":"1","author":"Stavropoulos","year":"2016","journal-title":"NPJ Genom Med"},{"issue":"1","key":"nrv220001r31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jimd.v43.1","article-title":"Recent advances in understanding the molecular genetic basis of mitochondrial disease.","volume":"43","author":"Thompson","year":"2020","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"nrv220001r32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gim.2017.107","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet Med"},{"issue":"12","key":"nrv220001r33","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41431-019-0477-3","article-title":"Early diagnosis of Pearson syndrome in neonatal intensive care following rapid mitochondrial genome sequencing in tandem with exome sequencing.","volume":"27","author":"Akesson","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"nrv220001r34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13039-015-0163-2","article-title":"Prader-Willi syndrome\u2014type 1 deletion, a consequence of an unbalanced translocation of chromosomes 13 and 15, easily to be mixed up with a Robertsonian translocation.","volume":"8","author":"Sheth","year":"2015","journal-title":"Mol Cytogenet"},{"issue":"6","key":"nrv220001r35","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go.","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"nrv220001r36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1017\/cjn.2020.229","article-title":"Newborn screening for spinal muscular atrophy: Ontario testing and follow-up recommendations.","volume":"48","author":"McMillan","year":"2021","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"nrv220001r37","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/gim.2018.37","article-title":"Meeting the challenges of implementing rapid genomic testing in acute pediatric care.","volume":"20","author":"Stark","year":"2018","journal-title":"Genet Med"},{"issue":"24","key":"nrv220001r38","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2020.7671","article-title":"Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system.","volume":"323","author":"Lunke","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"nrv220001r39","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/acn3.v7.7","article-title":"Utility of metabolic screening in neurological presentations of infancy.","volume":"7","author":"Djordjevic","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"nrv220001r40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00134-019-05552-x","article-title":"Whole-genome sequencing reveals that genetic conditions are frequent in intensively ill children.","volume":"45","author":"French","year":"2019","journal-title":"Intensive Care Med"},{"issue":"4","key":"nrv220001r41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41436-019-0708-6","article-title":"Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield.","volume":"22","author":"Gubbels","year":"2020","journal-title":"Genet Med"},{"issue":"17","key":"nrv220001r43","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease.","volume":"381","author":"Kim","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"nrv220001r44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41525-020-0137-0","article-title":"Children\u2019s rare disease cohorts: an integrative research and clinical genomics initiative.","volume":"5","author":"Rockowitz","year":"2020","journal-title":"NPJ Genom Med"},{"issue":"5","key":"nrv220001r45","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2020.10.003","article-title":"An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm.","volume":"107","author":"Dimmock","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"1","key":"nrv220001r46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-018-0049-4","article-title":"Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.","volume":"3","author":"Farnaes","year":"2018","journal-title":"NPJ Genom Med"},{"issue":"1","key":"nrv220001r47","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1038\/s41598-019-39796-w","article-title":"Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts.","volume":"9","author":"Oulas","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"nrv220001r48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1309\/LMWZH57BRWOPR5RQ","article-title":"Computational approach to annotating variants of unknown significance in clinical next generation sequencing.","volume":"46","author":"Schulz","year":"2015","journal-title":"Lab Med"},{"issue":"5","key":"nrv220001r49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"D1","key":"nrv220001r50","doi-asserted-by":"publisher","first-page":"D344","DOI":"10.1093\/nar\/gkaa977","article-title":"The InterPro protein families and domains database: 20 years on.","volume":"49","author":"Blum","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"nrv220001r51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans.","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"nrv220001r53","article-title":"Understanding genetic variants of uncertain significance.","author":"Joynt","year":"2021","journal-title":"Paediatr Child Health"},{"issue":"3","key":"nrv220001r54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10545-018-0146-7","article-title":"The functional genomics laboratory: functional validation of genetic variants.","volume":"41","author":"Rodenburg","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"nrv220001r55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1534\/genetics.117.203067","article-title":"Model organisms facilitate rare disease diagnosis and therapeutic research.","volume":"207","author":"Wangler","year":"2017","journal-title":"Genetics"},{"issue":"7","key":"nrv220001r56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068958","article-title":"Flow cytometry for the analysis of a-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies.","volume":"8","author":"Stevens","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"nrv220001r57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajhg.2013.01.016","article-title":"Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of a-dystroglycan.","volume":"92","author":"Stevens","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"2","key":"nrv220001r58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nmd.2011.08.006","article-title":"Flow cytometry analysis: a quantitative method for collagen VI deficiency screening.","volume":"22","author":"Kim","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"pt 3","key":"nrv220001r59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/brain\/awv352","article-title":"Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or \u201cclassical\u201d congenital myopathy.","volume":"139","author":"Zaharieva","year":"2016","journal-title":"Brain"},{"issue":"386","key":"nrv220001r60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in mendelian disease with transcriptome sequencing.","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"nrv220001r61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ajhg.2019.01.012","article-title":"Expanding the boundaries of RNA sequencing as a diagnostic tool for rare mendelian disease.","volume":"104","author":"Gonorazky","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"2","key":"nrv220001r62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-020-02164-4","article-title":"Multiomic elucidation of a coding 99-mer repeat-expansion skeletal muscle disease.","volume":"140","author":"Ruggieri","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"nrv220001r63","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1038\/s41467-020-19505-2","article-title":"The once and future gene therapy.","volume":"11","author":"Bulaklak","year":"2020","journal-title":"Nat Commun"},{"key":"nrv220001r64","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2019.05.005","article-title":"Impact of age and motor function in a phase 1\/2A study of infants with SMA type 1 receiving single-dose gene replacement therapy.","volume":"98","author":"Lowes","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"3","key":"nrv220001r65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JND-190403","article-title":"AVXS-101 (onasemnogene abeparvovec) for SMA1: comparative study with a prospective natural history cohort.","volume":"6","author":"Al-Zaidy","year":"2019","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"nrv220001r66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol"},{"issue":"10","key":"nrv220001r69","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy.","volume":"384","author":"Baranello","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"nrv220001r70","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymthe.2019.10.018","article-title":"AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathy.","volume":"28","author":"Dupont","year":"2020","journal-title":"Mol Ther"},{"key":"nrv220001r71","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated DNM2 knockdown prevents and reverts myotubular myopathy in mice.","volume":"8","author":"Tasfaout","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"nrv220001r72","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.v86.2","article-title":"Deoxynucleoside therapy for thymidine kinase 2-deficient myopathy.","volume":"86","author":"Dom\u00ednguez-Gonz\u00e1lez","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"nrv220001r73","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/ncomms6515","article-title":"MYBPC3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice.","volume":"5","author":"Mearini","year":"2014","journal-title":"Nat Commun"},{"key":"nrv220001r74","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1542\/peds.2018-1099C","article-title":"Perceived benefits, risks, and utility of newborn genomic sequencing in the BabySeq project.","volume":"143","author":"Pereira","year":"2019","journal-title":"Pediatrics"},{"issue":"4","key":"nrv220001r75","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajhg.2019.08.009","article-title":"A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants.","volume":"105","author":"Kingsmore","year":"2019","journal-title":"Am J Hum Genet"},{"key":"nrv220001r76","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1542\/peds.2018-1099D","article-title":"Rapid challenges: ethics and genomic neonatal intensive care.","volume":"143","author":"Gyngell","year":"2019","journal-title":"Pediatrics"},{"issue":"12","key":"nrv220001r77","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/s41436-020-0912-4","article-title":"Parental experiences of ultrarapid genomic testing for their critically unwell infants and children.","volume":"22","author":"Brett","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"nrv220001r78","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jgc4.v28.2","article-title":"Genetic counseling in pediatric acute care: Reflections on ultra-rapid genomic diagnoses in neonates.","volume":"28","author":"Ayres","year":"2019","journal-title":"J Genet Couns"},{"issue":"11","key":"nrv220001r79","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41431-020-0667-z","article-title":"Delivering genome sequencing for rapid genetic diagnosis in critically ill children: parent and professional views, experiences and challenges.","volume":"28","author":"Hill","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"nrv220001r42","unstructured":"Gene Transfer Clinical Study in X-linked Myotubular Myopathy (ASPIRO). ClinicalTrials.gov identifier: NCT03199469. Updated May 19, 2021. Accessed December 8, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03199469"},{"key":"nrv220001r52","unstructured":"Ellard? S, Baple? EL, Callaway? A, . ACGS best practice guidelines for variant classification in rare disease 2020. Accessed April 29, 2021. https:\/\/www.acgs.uk.com\/media\/11631\/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf"},{"key":"nrv220001r67","unstructured":"Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STR1VE). ClinicalTrials.gov identifier: NCT03306277. Updated June 14, 2021. Accessed April 29, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03306277"},{"key":"nrv220001r68","unstructured":"A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS396443) in Infants With Spinal Muscular Atrophy (SMA). ClinicalTrials.gov identifier: NCT01839656. Updated February 17, 2021. Accessed April 29, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01839656"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2789503\/jamaneurology_morton_2022_rv_220001_1649435695.60408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T15:02:00Z","timestamp":1649689320000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2789503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.0067","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}